#INDEGENE Q2FY25 Results

Revenue: ₹6,868 Cr (+8% YoY)
PAT: ₹917 Cr (+22.3% YoY)
EBITDA: 18.4%
AI-driven growth in $135B+ market
FY26E Target: ₹800-1050 (75% upside)#stockmarketscrash  #HealthTech #Investment
#INDEGENE #stockmarketscrash #HealthTech #Investment